A second clinical study to test how well BioLineRx’s motixafortide helps mobilize hematopoietic stem cells for use in gene…
Articles by Margarida Maia, PhD
Explosive synchronization in the brain, wherein a small change in the brain network causes it to sync up and undergo…
A bone marrow transplant approach that doesn’t use high-dose chemotherapy to prevent an immune response against a donor’s stem cells…
Oxbryta (voxelotor), an oral medication approved to treat sickle cell disease (SCD), prevented children’s red blood cells from…
While children with sickle cell anemia — the most common form of sickle cell disease — are vulnerable to…
Nearly 1 in 3 children and teens with sickle cell disease (SCD) reports persistent or chronic pain, according to…
A biomedical engineer at Kennesaw State University has been given a $426,000 grant to build a low-cost device helping to…
The first patient has been dosed in BEACON, a Phase 1/2 clinical trial of a transplant-based gene-editing stem cell therapy…
Saudi Arabia’s regulatory authorities have approved Casgevy (exagamglogene autotemcel), a one-time gene-editing therapy, to treat sickle cell disease…
A clinical project designed to test whether masitinib, AB Science’s experimental oral therapy for sickle cell disease (SCD), can…